AFP and neoplasm: Our study evaluated the diagnostic efficacy of serum inflammatory markers in identifying early TACE refractory patients and developed a TACE refractoriness model based on tumor size, bilobular invasion, APRI, and AFP level, which demonstrated a considerable connection with early TACE refractoriness in our intricate multivariate analysis.